DMSO represses inflammatory cytokine production from human blood cells and reduces autoimmune arthritis

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Elisia, Ingrid ^a   Nakamura, Hisae ^a   Lam, Vivian ^a   Hofs, Elyse ^a   Cederberg, Rachel ^a   Cait, Jessica ^b   Hughes, Michael R ^b   Lee, Leora ^a   Jia, William ^c   Adomat, Hans H ^d   Guns, Emma S ^d   McNagny, Kelly M ^b   Samudio, Ismael ^a   Krystal, Gerald ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; DIMETHYL SULFOXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTAGLANDIN E2; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; ARTICLE; AUTOIMMUNE ARTHRITIS; AUTOIMMUNE DISEASE; BLOOD CELL; CANCER INHIBITION; CELL DIFFERENTIATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENZYME PHOSPHORYLATION; ESCHERICHIA COLI; EX VIVO STUDY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; MACROPHAGE; MALE; MELANOMA; MELANOMA B16; MELANOMA CELL; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL SURVIVAL; CHEMICALLY INDUCED; CYTOLOGY; DRUG EFFECTS; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ARTHRITIS; BLOOD CELLS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOKINES; CYTOKINES; DIMETHYL SULFOXIDE; DINOPROSTONE; ESCHERICHIA COLI; FEMALE; HERPESVIRUS 1, HUMAN; HUMANS; MACROPHAGES; MALE; MELANOMA; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; SIGNAL TRANSDUCTION;

EID: 84973503238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152538     Document Type: Article

References (59)

1. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochemical Pharmacology. 2003; 65: 1035-1041. PMID: 12663039 doi: 10.1016/S0006-2952(03)00002-9
2. Capriotti K, Capriotti JA. Dimethyl sulfoxide: History, chemistry and clinical utility in dermatology. The Journal of Clinical and Aesthetic Dermatology. 2012; 5: 24-26. PMID: 23050031
3. Jimenez RAH, Willkens RF. Dimethyl Sulfoxide: a perspective of its use in rheumatoid disease. Journal of Laboratory and Clinical Medicine. 1982; 100: 489-500. PMID: 6750016
4. Pegg D. Principles of Cryopreservation. In: Day J, Stacey G, editors. Cryopreservation and Freeze-Drying Protocols. Humana Press; 2007. pp. 39-57.
5. Jacob SW, Bischel M, Herschler RJ. Dimethyl Sulfoxide (DMSO): A New Concept in Pharmacotherapy. Current Therapeutic Research, Clinical and Experimental. 1964; 6: 134-135. PMID: 14135298
6. Steinberg A. The employment of dimethyl sulfoxide as an antiinflammatory agent and steroid-transporter in diversified clinical diseases. Annals of the New York Academy of Sciences. 1967; 141: 532-550. PMID: 5232266 doi: 10.1111/j.1749-6632.1967.tb34922.x
7. Rosenbaum EE, Herschler RJ, Jacob SW. Dimethyl sulfoxide in musculoskeletal disorders. Journal of the American Medical Association. 1965; 192: 309-313. PMID: 14271981 doi: 10.1001/jama.1965. 03080170037009
8. Rosenbaum EE, Jacob SW. Dimethyl Sulfoxide (DMSO) in Musculoskeletal Injuries and Inflammations. II. Dimethyl Sulfoxide in Rheumatoid Arthritis, Degenerative Arthritis and Gouty Arthritis. Northwest Medicine. 1964; 63: 227-229. PMID: 14137825
9. Ehrlich GE, Joseph R. Dimethyl Sulfoxide in Scleroderma. Pennsylvannia Medicine. 1965; 68: 51-53. PMID: 5856390
10. DMSO ban: Was it handled properly? Journal of the American Medical Association. 1966; 195: A33-A34. doi: 10.1001/jama.1966.03100010017005
11. Dimethyl sulfoxide: Controversy and current status-1981. Journal of the American Medical Association. 1982; 248: 1369-1371. doi: 10.1001/jama.1982.03330110061032
12. Myrer JW, Heckmann R, Francis RS. Topically applied dimethyl sulfoxide: Its effects on inflammation and healing of a contusion. The American Journal of Sports Medicine. 1986; 14: 165-169. PMID: 3717490
13. U.S. Food and Drug Administration. 187 Fake Cancer "Cures" Consumers Should Avoid. 2009. Available: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/ucm171057.htm
14. WebMD. DMSO (DIMETHYLSULFOXIDE). 2014. Available: http://www.webmd.com/vitaminssupplements/ingredientmono-874-dmso%20dimethylsulfoxide.aspx?activeingredientid= 874&activeingredientname=dmso%20dimethylsulfoxide
15. Camelot Cancer Care Inc. 2015. Available: https://camelotcancercare.is/faqs/
16. Trice JM, Pinals RS. Dimethyl sulfoxide: A review of its use in the rheumatic disorders. Seminars in Arthritis and Rheumatism. 1985; 15: 45-60. PMID: 3898376
17. Muir M. DMSO. Alternative and Complementary Therapies. 1996; 2: 230-235. doi: 10.1089/act.1996. 2.230
18. Hosoi J, Abe E, Suda T, Kuroki T. Regulation of melanin synthesis of B16 mouse melanoma Cells by 1α, 25-Dihydroxyvitamin D3 and Retinoic Acid. Cancer Research. 1985; 45: 1474-1478. PMID: 2983883
19. Overwijk WW, Restifo NP. B16 as a mouse model for human melanoma. Current Protocols in Immunology. 2001; Chapter 20:Unit 20.1 PMID: 18432774 doi: 10.1002/0471142735.im2001s39
20. Weisser S, McLarren K, Kuroda E, Sly L. Generation and Characterization of Murine Alternatively Activated Macrophages. In: Helgason CD, Miller CL, editors. Basic Cell Culture Protocols. Humana Press; 2013. pp. 225-239. PMID: 23179835 doi: 10.1007/978-1-62703-128-8-14
21. Nigrovic P, Shin K. Evaluation of synovial mast cell functions in autoimmune arthritis. In: Hughes MR, McNagny KM, editors. Mast Cells. Springer New York; 2015. pp. 423-442. PMID: 25388266 doi: 10.1007/978-1-4939-1568-2-26
22. Blanchet MR, Gold M, Maltby S, Bennett J, Petri B, Kubes P, et al. Loss of CD34 leads to exacerbated autoimmune arthritis through increased vascular permeability. The Journal of Immunology. 2010; 184: 1292-1299. PMID: 20038636 doi: 10.4049/jimmunol.0900808
23. Hucker HB, Miller JK, Hochberg A, Brobyn RD, Riordan FH, Calesnick B. Studies on the absorption, excretion and metabolism of dimethylsulfoxide (DMSO) in man. Journal of Pharmacology and Experimental Therapeutics. 1967; 155: 309-317. PMID: 6025521
24. Becker K, Schroecksnadel S, Gostner J, Zaknun C, Schennach H, Überall F, et al. Comparison of in vitro tests for antioxidant and immunomodulatory capacities of compounds. Phytomedicine. 2014; 21: 164-171. PMID: 24041614 doi: 10.1016/j.phymed.2013.08.008
25. Stølevik SB, Nygaard UC, Namork E, Granum B, Pellerud A, van Leeuwen DM, et al. In vitro cytokine release from human peripheral blood mononuclear cells in the assessment of the immunotoxic potential of chemicals. Toxicology in Vitro. 2011; 25: 555-562. PMID: 21144890 doi: 10.1016/j.tiv.2010.11.021
26. Martinon F, Burns K, Tschopp J. The Inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Molecular Cell. 2002; 10: 417-426. PMID: 12191486 doi: 10.1016/S1097-2765(02)00599-3
27. Zlotnik A, Yoshie O. Chemokines: A New Classification System and Their Role in Immunity. Immunity. 2000; 12: 121-127. PMID: 10714678 doi: 10.1016/S1074-7613(00)80165-X
28. Perry AK, Chen G, Zheng D, Tang H, Cheng G. The host type I interferon response to viral and bacterial infections. Cell Research. 2005; 15: 407-422. PMID: 15987599
29. Reed KW, Yalkowsky SH. Lysis of human red blood cells in the presence of various cosolvents. PDA Journal of Pharmaceutical Science and Technology. 1985; 39: 64-69. PMID: 3559834
30. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cellular Signalling. 2001; 13: 85-94. PMID: 11257452 doi: 10.1016/S0898-6568(00)00149-2
31. Nordenberg J, Wasserman L, Beery E, Aloni D, Malik H, Stenzel KH, et al. Growth inhibition of murine melanoma by butyric acid and dimethylsulfoxide. Experimental Cell Research. 1986; 162: 77-85. PMID: 3079593
32. Monach PA, Mathis D, Benoist C. The K/BxN arthritis model. In: Current Protocols in Immunology. John Wiley & Sons, Inc; 2001. PMID: 18491295 doi: 10.1002/0471142735.im1522s81
33. Monach P, Hattori K, Huang H, Hyatt E, Morse J, Nguyen L, et al. The K/BxN mouse model of inflammatory arthritis: Theory and practice. 2007; 136: 269-282. PMID: 17983155
34. Kyburz D, Corr M. The KRN mouse model of inflammatory arthritis. Springer Seminars in Immunopathology. 2003; 25: 79-90. PMID: 12904893 doi: 10.1007/s00281-003-0131-5
35. Ahn H, Kim J, Jeung EB, Lee GS. Dimethyl sulfoxide inhibits NLRP3 inflammasome activation. Immunobiology. 2014; 219: 315-322. PMID: 24380723 doi: 10.1016/j.imbio.2013.11.003
36. Hollebeeck S, Raas T, Piront N, Schneider YJ, Toussaint O, Larondelle Y, et al. Dimethyl sulfoxide (DMSO) attenuates the inflammatory response in the in vitro intestinal Caco-2 cell model. Toxicology Letters. 2011; 206: 268-275. PMID: 21878375 doi: 10.1016/j.toxlet.2011.08.010
37. Kloesch B, Liszt M, Broell J, Steiner G. Dimethyl sulphoxide and dimethyl sulphone are potent inhibitors of IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2. Life Sciences. 2011; 89: 473-478. PMID: 21821055 doi: 10.1016/j.lfs.2011.07.015
38. DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG. Regulation of interleukin 8 gene expression by oxidant stress. The Journal of Biological Chemistry. 1993; 268: 25568-25576. PMID: 8244994
39. Gurtovenko AA, Anwar J. Modulating the structure and properties of cell membranes: The molecular mechanism of action of dimethyl sulfoxide. The Journal of Physical Chemistry B. 2008; 111: 10453-10460. PMID: 17661513 doi: 10.1021/jp073113e
40. Da Violante G, Zerrouk N, Richard I, Provot G, Chaumeil JC, Arnaud P. Evaluation of the Cytotoxicity Effect of Dimethyl Sulfoxide (DMSO) on Caco2/TC7 Colon Tumor Cell Cultures. Biological and Pharmaceutical Bulletin. 2002; 25: 1600-1603. PMID: 12499647 doi: 10.1248/bpb.25.1600
41. Teigland MB, Saurino VR. Clinical Evaluation of Dimethyl Sulfoxide in Equine Applications. Annals of the New York Academy of Sciences. 1967; 141: 471-477. PMID: 4167019
42. Layman DL, Jacob SW. The absorption, metabolism and excretion of dimethyl sulfoxide by Rhesus monkeys. Life Sciences. 1985; 37: 2431-2437. PMID: 4079657
43. Kolb KH, Jaenicke G, Kramer M, Schulze PE. Absorption, distribution, and elimination of labeled dimethyl sulfoxide in man and animals. Annals of the New York Academy of Sciences. 1967; 141: 85-95. PMID: 5232278
44. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Radical Biology and Medicine. 2000; 28: 463-499. PMID: 10699758 doi: 10.1016/S0891-5849(99)00242-7
45. Ngkelo A, Meja K, Yeadon M, Adcock I, Kirkham P. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Gialpha dependent PI-3kinase signalling. Journal of Inflammation. 2012; 9: 1. PMID: 22239975 doi: 10.1186/1476-9255-9-1
46. Siracký J, Blasko M, Borovanský J. Stimulation of differentiation in human melanoma cells by dimethyl sulphoxide (DMSO). Neoplasma. 1985; 32: 635-638. PMID: 4088387
47. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proceedings of the National Academy of Sciences. 1978; 75: 2458-2462. PMID: 276884
48. Cox Media Group. Camelot Cancer Care shut down following suspicious death. 2014. Available: http://www.fox23.com/news/news/local/camelot-cancer-care-shut-down-following-suspicious/nh236/#sthash.Pe4sJ2fm.dpuf.
49. Aita K, Irie H, Tanuma Y, Toida S, Okuma Y, Mori S, et al. Apoptosis in murine lymphoid organs following intraperitoneal administration of dimethyl sulfoxide (DMSO). Experimental and Molecular Pathology. 2005; 79: 265-271. PMID: 16154562 doi: 10.1016/j.yexmp.2005.07.001
50. Deng R, Wang SM, Yin T, Ye TH, Shen GB, Li L, et al. Dimethyl sulfoxide suppresses mouse 4T1 breast cancer growth by modulating tumor-associated macrophage differentiation. Journal of Breast Cancer. 2014; 17: 25-32. PMID: 24744794 doi: 10.4048/jbc.2014.17.1.25
51. Matsumoto J. Clinical trials of dimethyl sulfoxide in rheumatoid arthritis patients in Japan. Annals of the New York Academy of Sciences. 1967; 141: 560-568. PMID: 5342265
52. Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. The Journal of Immunology. 2001; 167: 1601-1608. PMID: 11466382
53. Ditzel HJ. The K/BxN mouse: a model of human inflammatory arthritis. Trends in Molecular Medicine. 2004; 10: 40-45. PMID: 14720585 doi: 10.1016/j.molmed.2003.11.004
54. Wright HL, Moots RJ, Bucknall RC, Edwards SW. Neutrophil function in inflammation and inflammatory diseases. Rheumatology. 2010; 49: 1618-1631. PMID: 20338884 doi: 10.1093/rheumatology/keq045
55. Antony VB, Sahn SA, Repine JE. Dimethyl sulfoxide inhibits phagocyte influx into infected pleural spaces and phagocyte locomotion in vitro. Inflammation. 1983; 7: 377-385. PMID: 6654475
56. Sulzberger MB, Cortese TA, Fishman L, Wiley HS, Peyakovich PS. Some effects of DMSO on human skin in vivo. Annals of the New York Academy of Sciences. 1967; 141: 437-450. PMID: 5232255 doi: 10.1111/j.1749-6632.1967.tb34908.x
57. Colucci M, Maione F, Bonito MC, Piscopo A, Di Giannuario A, Pieretti S. New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammation. Pharmacological Research. 2008; 57: 419-425. PMID: 18508278 doi: 10.1016/j.phrs.2008.04.004
58. Görög P, Kovács IB. Effect of dimethyl sulfoxide (DMSO) on various experimental inflammations. Current Therapeutic Research, Clinical and Experimental. 1968; 10: 486-493. PMID: 4971653
59. Preziosi P, Scapagnini U. Action of dimethylsulfoxide on acute inflammatory reactions. Current Therapeutic Research, Clinical and Experimental. 1966; 8: 261-264. PMID: 4956389